Alvogen on Wednesday announced that it will acquire a portfolio of four pharmaceutical products in the United States from Pfizer.
Vermont on Friday became the last state in the nation to legalize electronic prescriptions for controlled substances — a measure that many states have adopted as a way to combat the abuse of controlled substances and prevent individuals from resorting to fraudulent paper prescriptions.
Amgen announced Friday that the Food and Drug Administration had approved its new cholesterol treatment Repatha (evolocumab) injection.
Mylan will now move forward with its plans to tender a formal offer directly to Perrigo’s shareholders.
Dr. Reddy’s Laboratories on Thursday announced several senior level changes in their global management structure.
Aurobindo Pharma Limited announced Thursday that it had received approval from the Food and Drug Administration for its entecavir tablets in 0.5- and 1-mg dosage strengths.
When asked about readiness in the face of a cyber-attack, 66% of executives at health plans said they were prepared, while only 53% of providers said they were ready.
See some of the biggest innovations in pharmacy technology from the 2015 National Association of Chain Drug Stores’ Total Store Expo.
Sermo, a social network for physicians, announced Wednesday that 69% of doctors think parents are either completely or mostly to blame for the childhood obesity epidemic.
Mylan this week announced the launch of its generic version of Pfizer’s Zosyn (piperacillin and tazobactam) injection.